SEC Form 4 · accession 0001193125-26-309331
Q32 Bio Inc. · QTTB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shelia M. Violette
Officer — Chief Scientific Officer
Period of report
Jul 16, 2026
Accepted (ET)
Jul 20, 2026 · 9:31 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001661998
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 16, 2026 | A | 37,500 | $0.00 | A | 130,569 | D | |
| Common StockF2 | holding | — | — | — | 36,277 | I | By Violette Holdings LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of Issuer common stock underlying performance-based restricted stock units ("PSUs") granted on July 6, 2026, which vested on July 16, 2026 with respect to a performance-based condition, upon achievement of the closing of a financing of at least $100,000,000 in gross proceeds on or before December 31, 2026. Such PSUs are also subject to a time-based condition, which provides that the PSUs shall vest in equal quarterly installments over three years from July 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Each PSU represents a contingent right to receive one share of Issuer common stock.
- F2Shares held by Violette Holdings LLC ("Violette Holdings"). The Reporting Person is a manager of Violette Holdings and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose.